Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

NCT06420206 | Recruiting

• 1 other identifier: 2019-1024
• Study Type: interventional
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

To improve quality of life for participants with advanced cancer, support their families, and lower overall cost of care.

Conditions

Lung Cancer; Gastrointestinal Cancer

Outcome Measures

Primary Outcomes (1)

• Quality Of Life Questionnaire

  through study completion; an average of 1 year

Study Arms (2)

Acute Cancer Care Center

OTHER

In Group 1, participants will receive the usual standard of care, during your emergency room visit, provided by the Acute Cancer Care Center (ACCC) treating doctor who will address symptoms and other medical problems that brought the participant to the emergency room.

Other: Standard of Care (Acute Cancer Care Center)

Goals of Care

OTHER

In Group 2, participants will receive the above usual standard of care plus goals of care (GOC) intervention.

Other: Standard of Care (Goals of Care)

Interventions

Standard of Care (Acute Cancer Care Center) OTHER

In Group 1, participants will receive the usual standard of care by an emergency care physician not trained in palliative care.

Acute Cancer Care Center

Standard of Care (Goals of Care) OTHER

In Group 2, participants will receive standard of care plus palliative care intervention by an emergency care physician trained in palliative care.

Goals of Care

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participant is at least 18 years old presenting to the triage area of the MDACC ACCC for treatment
• Participant has advanced lung or GI cancer. Advanced cancer patient defined as: locally recurrent or metastatic for which there is no curative treatment available.
• Participant screens positive for at least 2 of 3 triple threat conditions (dyspnea, altered mental status, or poor performance status)
• Participant has the ability to speak and write in English
• Participant has the ability to provide consent OR is accompanied by a LAR able to provide consent

You may not qualify if:

• Participant is already enrolled in hospice
• Participant is comatose
• Participant has severe intellectual disability
• Participant has a history of dementia documented in the medical records
• Participant has baseline communication barriers such as aphasia or deafness
• Participant is new to MDACC, without established oncology care at our institution at time of ACCC arrival
• Participant is 18 years or older, currently cared for by pediatrics service
• Pregnant women
• Prisoners

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

MD Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

• MD Anderson Cancer Center

MeSH Terms

Conditions

Lung Neoplasms; Gastrointestinal Neoplasms

Interventions

Standard of Care; Patient Care Planning

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases; Digestive System Neoplasms; Digestive System Diseases; Gastrointestinal Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health Care; Quality of Health Care; Health Services Administration; Health Care Quality, Access, and Evaluation; Comprehensive Health Care; Patient Care Management

Study Officials

• Ahmed Elsayem, MD,MPH

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Ahmed Elsayem, MD,MPH

CONTACT

(713) 745-9911; aelsayem@mdanderson.org

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 14, 2024
• First Posted: May 17, 2024
• Study Start: May 14, 2024
• Primary Completion (Estimated): February 2, 2027
• Study Completion (Estimated): February 2, 2027
• Last Updated: December 30, 2025

Record last verified: 2025-12

Locations

US (1)